Does FILGRASTIM Cause Carcinoembryonic antigen increased? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Carcinoembryonic antigen increased have been filed in association with FILGRASTIM (NYPOZI txid). This represents 0.1% of all adverse event reports for FILGRASTIM.
9
Reports of Carcinoembryonic antigen increased with FILGRASTIM
0.1%
of all FILGRASTIM reports
0
Deaths
0
Hospitalizations
How Dangerous Is Carcinoembryonic antigen increased From FILGRASTIM?
Of the 9 reports, and 8 (88.9%) were considered life-threatening.
Is Carcinoembryonic antigen increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FILGRASTIM. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does FILGRASTIM Cause?
Off label use (1,930)
Febrile neutropenia (1,570)
Neutropenia (1,431)
Death (1,213)
Pyrexia (1,085)
Diarrhoea (739)
Nausea (718)
Bone pain (706)
Thrombocytopenia (697)
Anaemia (626)
What Other Drugs Cause Carcinoembryonic antigen increased?
RIBOCICLIB (143)
LETROZOLE (115)
CAPECITABINE (113)
FULVESTRANT (105)
BEVACIZUMAB (102)
REGORAFENIB (91)
OXALIPLATIN (88)
OSIMERTINIB (82)
PALBOCICLIB (78)
FLUOROURACIL (71)
Which FILGRASTIM Alternatives Have Lower Carcinoembryonic antigen increased Risk?
FILGRASTIM vs FILGRASTIM-AAFI
FILGRASTIM vs FILGRASTIM-SNDZ
FILGRASTIM vs FINASTERIDE
FILGRASTIM vs FINASTERIDE\TAMSULOSIN
FILGRASTIM vs FINERENONE